Sandy Spring Bank’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-100
Closed -$72 1351
2024
Q1
$72 Hold
100
﹤0.01% 1216
2023
Q4
$85 Hold
100
﹤0.01% 1156
2023
Q3
$137 Hold
100
﹤0.01% 1159
2023
Q2
$252 Hold
100
﹤0.01% 1183
2023
Q1
$227 Hold
100
﹤0.01% 1125
2022
Q4
$140 Buy
+100
New +$168 ﹤0.01% 1121
2022
Q1
Sell
-100
Closed -$1K 1253
2021
Q4
$1K Buy
+100
New +$1.03K ﹤0.01% 1202

Other funds holding VAXX

Sandy Spring Bank's VAXX Position: Q2 2024 in Review

Sandy Spring Bank sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 100 shares — an estimated $72 sold.

Sandy Spring Bank first reported a position in VAXX in Q4 2021 and held it in 7 quarters. The position peaked at $1K in Q4 2021. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Sandy Spring Bank reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Sandy Spring Bank sold 100 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $72.
  • Sandy Spring Bank first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • Sandy Spring Bank's Vaxxinity, Inc. Class A Common Stock position peaked at $1K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Sandy Spring Bank's 13F filing for Q2 2024, filed 6 Aug 2024.